Fitzgerald, D W <br/><br/>
An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study).  [electronic resource] 

 -  The Journal of infectious diseases  Mar 2011 
 - 765-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-6613 
<br/><br/><label>Standard No.: </label>10.1093/infdis/jiq114  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--immunology<br/>Adenoviruses, Human--genetics<br/>Adult<br/>Anti-Retroviral Agents--therapeutic use<br/>Blotting, Western<br/>CD4 Lymphocyte Count<br/>CD4-Positive T-Lymphocytes--immunology<br/>Circumcision, Male<br/>Disease-Free Survival<br/>Double-Blind Method<br/>Genetic Vectors<br/>HIV Infections--drug therapy<br/>HIV-1--genetics<br/>Humans<br/>Immunity, Cellular<br/>Male<br/>Middle Aged<br/>Placebos<br/>Proportional Hazards Models<br/>RNA, Viral--blood<br/>Viral Load--drug effects<br/>Young Adult